Skip to main content
PLOS One logoLink to PLOS One
. 2008 Jul 17;3(7):10.1371/annotation/8183042c-af40-4227-8a00-8f362de22220. doi: 10.1371/annotation/8183042c-af40-4227-8a00-8f362de22220

Correction: A Unique Carrier for Delivery of Therapeutic Compounds beyond the Blood-Brain Barrier

Delara Karkan, Cheryl Pfeifer, Timothy Z Vitalis, Gavin Arthur, Maki Ujiie, Qingqi Chen, Sam Tsai, Gerrasimo Koliatis, Reinhard Gabathuler, Wilfred A Jefferies
PMCID: PMC2645281

The symbols in the first and second sentences of the legend to Figure 8 are incorrect. The correct Figure 8 legend should read: a) Percentage (%) survival of mice bearing intracranial ZR-75-1 mammary tumors and treated with p97-ADR conjugate SYN002 (5.5 mg/kg ADR, ▲-▲), ADR (20mg/kg, ■-■) or PBS (●-●). b) Percentage (%) survival of mice bearing intracranial C6 glioma tumors and treated with p97-ADR conjugate SYN018 (0.49mg/kg ADR, ▲-▲) or PBS (●-●).


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES